Client Services
1800 800 629

  • MIMS Drugs4dent®

    Towards Safer Medication Use: A Tailored Medicines Resource For Dental Practitioners
    +Read More

  • Don’t Rush to Crush+ in eMIMS

    The latest Don’t Rush to Crush release marks the move to a fully digital resource, with rolling updates, with quarterly updates by therapeutic class. To add to your current subscription or to subscribe please call our Client Services Team on 1800 800 629
    +Read More

  • MIMS for Android App

    Now, Android users can find comprehensive, up to date medicines information at the tip of their fingers.
    +Read More

  • eMIMS Classic

    Now eMIMS is available with a choice of platform. eMIMSCloud is internet-based and can be accessed from wherever you are, whereas eMIMS Classic is downloaded to sit on your hard drive. Choose the right eMIMS for you, to suit the way you work.
    +Read More

  • eMIMSCloud

    Now eMIMS is available with a choice of platform. eMIMSCloud is internet-based and can be accessed from wherever you are, whereas eMIMS Classic is downloaded to sit on your hard drive. Choose the right eMIMS for you, to suit the way you work.
    +Read More

  • IMgateway

    Available in eMIMS, this unique, evidence based drug herb and food interaction base developed by a team at the University Of Sydney School Of Pharmacy, provide the health professional with the ability to retrieve information on clinically-significant drug and herb interactions.
    +Read More

  • MIMS - Celebrating 60 momentous years

    In November 2023 MIMS celebrates its 60th birthday. We would like to share some of our milestones.
    +Read More

  • Welcome to MIMS

    Independently edited and abbreviated information on Australian prescription medicines as well as the most commonly used and prescribed over-the-counter and alternative therapies.
    +Read More

  • Markets

    Loved and trusted. The wide spectrum of the Australian healthcare market uses us every day! Servicing the Australian market for just on 60 years.
    +Read More

  • MIMS: A World of Knowledge

    Australia's most trusted and comprehensive drug reference system, used by more than 21,000 healthcare professionals, MIMS offers a wide range of digital products to cover desktop, mobile and integrated data.
    +Read More

  • MIMS: The Gold Standard

    "It has a wealth of information and it makes me confident choosing the right drug for the right person."
    - Survey participant 2010
    +Read More

  • Safer Use of Medicines

    Working closely with healthcare professionals to give peace of mind in medication management, MIMS is a key partner in the safer use of medicines in Australian clinical practice.
    +Read More

  • Support

    MIMS is dedicated to providing responsive service and support with our team of clinical, administrative and technical support officers ready to take your enquiry.
    +Read More
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13

File

Release Date: 01 May 2025
eMIMS Version: updates April 2025 DVD release only
File Name: FullEmimsMay25.exe
Size: 74.8 MB
Description

What's New (Full update)

The May 2025 update includes

  • Additions to the PBS:
    • Abilify Asimtufii Prolonged release suspension for injection (Aripiprazole) Lundbeck (3c)
      720 mg/2.4 mL (prefilled syringe) [1]: Authority (Streamlined) - PBS/RPBS
      960 mg/3.2 mL (prefilled syringe) [1]: Authority (Streamlined) - PBS/RPBS
    • Amvuttra Solution for injection (Vutrisiran) Medison Pharma (3e)
      25 mg/0.5 mL (prefilled syringe) [1]: Section 100 (Highly Specialised Drugs) - Public - Authority
      25 mg/0.5 mL (prefilled syringe) [1]: Section 100 (Highly Specialised Drugs) - Private - Authority
    • APOHealth Osteo Relief Paracetamol Modified release tablets (Paracetamol) Arrotex (4b)
      665 mg (blister) [96] x 2: Restricted - Palliative Care
    • ARX-Ezetimibe Tablets (Ezetimibe) Arrotex (2f)
      10 mg [30]: PBS/RPBS
      10 mg [30] x 2: Restricted - PBS/RPBS
    • Azacitidine SXP Powder for injection (Azacitidine) Southern XP IP (9b)
      100 mg [1] x 14: Section 100 (Highly Specialised Drugs) - Public - Authority
      100 mg [1] x 14: Section 100 (Highly Specialised Drugs) - Private - Authority
      100 mg [1] x 14: Section 100 (Highly Specialised Drugs) - Private - Authority (Streamlined)
      100 mg [1] x 14: Section 100 (Highly Specialised Drugs) - Public - Authority (Streamlined)
    • Bosentan Viatris Tablets (Bosentan) Alphapharm (2n)
      125 mg [60]: Section 100 (Highly Specialised Drugs) - Private - Authority
      125 mg [60]: Section 100 (Highly Specialised Drugs) - Public - Authority
    • Chemists' Own Osteo Relief Paracetamol Modified release tablets (Paracetamol) Arrotex (4b)
      665 mg [96] x 2: Restricted - PBS/RPBS
    • Chemists' Own Osteo Relief Paracetamol Modified release tablets (Paracetamol) Arrotex (4b)
      665 mg [96] x 2: Restricted - Palliative Care
    • Epkinly Concentrate for injection (Epcoritamab) AbbVie (9f)
      4 mg/0.8 mL (dilute to use) [1]: Authority - PBS/RPBS
      4 mg/0.8 mL (dilute to use) [1]: Section 100 (Chemo) - CPAP Public Hospital (CT) - Authority
    • Epkinly Solution for injection (Epcoritamab) AbbVie (9f)
      48 mg/0.8 mL (ready to use) [1]: Authority - PBS/RPBS
      48 mg/0.8 mL (ready to use) [1]: Authority (Streamlined) - PBS/RPBS
      48 mg/0.8 mL (ready to use) [1]: Section 100 (Chemo) - CPAP Public Hospital (CT) - Authority
      48 mg/0.8 mL (ready to use) [1]: Section 100 (Chemo) - CPAP Public Hospital (CT) - Authority (Streamlined)
    • Essential Care Jr Powder for oral suspension (multiple actives) Cortex (19a)
      400 g [1] x 8: Authority - PBS/RPBS
    • Fintepla Oral solution (Fenfluramine) UCB Pharma (3g)
      2.2 mg/mL 360 mL [1]: Authority - PBS/RPBS
    • Ganirelix Lupin Solution for injection (Ganirelix) Lupin (6c)
      250 mcg/0.5 mL (prefilled syringe) [1] x 10: Section 100 (IVF Treatment) - Authority (Streamlined)
      250 mcg/0.5 mL (prefilled syringe) [5] x 2: Section 100 (IVF Treatment) - Authority (Streamlined)
    • Nebaloc Tablets (Nebivolol) Pharmacor (2b)
      5 mg [28]: Restricted - PBS/RPBS
      5 mg [28] x 2: Restricted - PBS/RPBS
      10 mg [28]: Restricted - PBS/RPBS
      10 mg [28] x 2: Restricted - PBS/RPBS
    • Opsynvi 10/40 Tablets (Macitentan; tadalafil) Janssen-Cilag (2n)
      10 mg/40 mg [30]: Section 100 (Highly Specialised Drugs) - Public - Authority
      10 mg/40 mg [30]: Section 100 (Highly Specialised Drugs) - Private - Authority
    • Oridopa 100/25 Tablets (Levodopa; carbidopa) Orion Pharma (3f)
      100 mg/25 mg [100]: PBS/RPBS
      100 mg/25 mg [100] x 2: Restricted - PBS/RPBS
    • Osteomol 665 Paracetamol Modified release tablets (Paracetamol) Pharmacor (4b)
      665 mg [96] x 2: Restricted - Palliative Care
    • Parapane Osteo Modified release tablets (Paracetamol) Alphapharm (4b)
      665 mg [96] x 2: Restricted - Palliative Care
    • PKU Glytactin Build 10 Powder for oral liquid (multiple actives) Cortex (19b)
      15 g (sachet) [30] x 4: Restricted - PBS/RPBS
    • Prasugrel Lupin Tablets (Prasugrel) Southern Cross Pharma (2k)
      5 mg [28]: Authority (Streamlined) - PBS/RPBS
      10 mg [28]: Authority (Streamlined) - PBS/RPBS
    • Prazosin Hydrochloride Capsules, USP (Novitium Pharma, USA) (Medsurge) (Prazosin) Medsurge (2a)
      1 mg (S19A TGA) [100]: PBS/RPBS
      1 mg (S19A TGA) [100] x 2: Restricted - PBS/RPBS
    • Radicava Concentrate for infusion (Edaravone) Teva (3e)
      30 mg/20 mL [10] x 2: Section 100 (Highly Specialised Drugs) - Community Access - Authority
      30 mg/20 mL [28]: Section 100 (Highly Specialised Drugs) - Private - Authority
      30 mg/20 mL [28]: Section 100 (Highly Specialised Drugs) - Public - Authority
    • Rivaxib Tablets (Rivaroxaban) Alphapharm (2k)
      10 mg [30]: Authority (Streamlined) - PBS/RPBS
      10 mg [30] x 2: Authority (Streamlined) - PBS/RPBS
      15 mg [28]: Authority (Streamlined) - PBS/RPBS
      15 mg [28] x 2: Authority (Streamlined) - PBS/RPBS
      15 mg [42]: Authority (Streamlined) - PBS/RPBS
      20 mg [28]: Authority (Streamlined) - PBS/RPBS
      20 mg [28] x 2: Authority (Streamlined) - PBS/RPBS
    • Rybrevant Concentrate for infusion (Amivantamab) Janssen-Cilag (9f)
      350 mg/7 mL [1]: Section 100 (Chemo, Revised Arrangements) - Public - Authority
      350 mg/7 mL [1]: Section 100 (Chemo, Revised Arrangements) - Private - Authority
    • Ryeqo Tablets (multiple actives) Gedeon Richter (6c)
      40 mg/1 mg/0.5 mg [28]: Authority (Streamlined) - PBS/RPBS
    • Slinda Tablets (Drospirenone) Besins Healthcare (18b)
      4 mg [28] x 4: PBS/RPBS
    • Spravato Nasal spray (Esketamine) Janssen-Cilag (3d)
      28 mg/2 actuation 2 actuation [1] x 4: Section 100 (Highly Specialised Drugs) - Private - Authority
      28 mg/2 actuation 2 actuation [1] x 4: Authority - PBS/RPBS
      28 mg/2 actuation 2 actuation [1] x 4: Section 100 (Highly Specialised Drugs) - Public - Authority
      28 mg/2 actuation 2 actuation [1] x 8: Section 100 (Highly Specialised Drugs) - Private - Authority
      28 mg/2 actuation 2 actuation [1] x 8: Section 100 (Highly Specialised Drugs) - Public - Authority
      28 mg/2 actuation 2 actuation [1] x 8: Authority - PBS/RPBS
    • Tenofovir/Emtricitabine 300/200 APX Tablets (Tenofovir disoproxil fumarate; emtricitabine) Arrotex (8i)
      300 mg/200 mg [30]: Restricted - PBS/RPBS
      300 mg/200 mg [30] x 2: Section 100 (Highly Specialised Drugs) - Community Access - Authority (Streamlined)
    • Tranexamic Acid Waymade Tablets (Tranexamic acid) Waymade Australia (2l)
      500 mg [100]: PBS/RPBS
    • Vabysmo Solution for injection Prefilled syringe (Faricimab) Roche (14g)
      6 mg/0.05 mL (21 mg/0.175 mL; prefilled syringe) [1]: Authority - PBS/RPBS
      6 mg/0.05 mL (21 mg/0.175 mL; prefilled syringe) [1]: Authority (Streamlined) - PBS/RPBS
    • Xobet Cream (Clobetasol propionate) Arrotex (15e)
      0.05% 30 g [1]: Restricted - PBS/RPBS
    • Xobet Ointment (Clobetasol propionate) Arrotex (15e)
      0.05% 30 g [1]: Restricted - PBS/RPBS
  • Restriction changes:
    • Abrilada Prefilled pen (Adalimumab) Pfizer (10c)
      40 mg/0.8 mL (prefilled pen) [2]: Authority - PBS/RPBS
    • Abrilada Prefilled syringe (Adalimumab) Pfizer (10c)
      40 mg/0.8 mL (prefilled syringe) [2]: Authority - PBS/RPBS
    • Adalicip Prefilled pen (Adalimumab) Cipla (10c)
      40 mg/0.4 mL (Prefilled pen) [2]: Authority - PBS/RPBS
    • Amgevita Prefilled syringe (Adalimumab) Amgen (10c)
      40 mg/0.8 mL (prefilled syringe) [2]: Authority - PBS/RPBS
    • Amgevita Sureclick Prefilled Pen (Adalimumab) Amgen (10c)
      40 mg/0.8 mL (prefilled pen) [2]: Authority - PBS/RPBS
    • Camzyos Capsules (Mavacamten) Bristol-Myers Squibb (2g)
      2.5 mg [28]: Authority - PBS/RPBS
      5 mg [28]: Authority - PBS/RPBS
      10 mg [28]: Authority - PBS/RPBS
      15 mg [28]: Authority - PBS/RPBS
    • Cipla Gefitinib Tablets (Gefitinib) Cipla (9f)
      250 mg [30]: Authority - PBS/RPBS
    • Erlotinib ARX Tablets (Erlotinib) Accelagen (9f)
      25 mg [30]: Authority - PBS/RPBS
      100 mg [30]: Authority - PBS/RPBS
      150 mg [30]: Authority - PBS/RPBS
    • Erlotinib Sandoz Tablets (Erlotinib) Sandoz (9f)
      25 mg [30]: Authority - PBS/RPBS
      100 mg [30]: Authority - PBS/RPBS
      150 mg [30]: Authority - PBS/RPBS
    • Giotrif Tablets (Afatinib) Boehringer Ingelheim (9f)
      20 mg [28]: Authority - PBS/RPBS
      30 mg [28]: Authority - PBS/RPBS
      40 mg [28]: Authority - PBS/RPBS
      50 mg [28]: Authority - PBS/RPBS
    • Hadlima Prefilled syringe (Adalimumab) Samsung Bioepis (10c)
      40 mg/0.4 mL (prefilled syringe) [2]: Authority - PBS/RPBS
      40 mg/0.8 mL (prefilled syringe) [2]: Authority - PBS/RPBS
    • Hadlima Pushtouch Auto-Injector Pen (Adalimumab) Samsung Bioepis (10c)
      40 mg/0.4 mL (prefilled pen) [2]: Authority - PBS/RPBS
      40 mg/0.8 mL (prefilled pen) [2]: Authority - PBS/RPBS
    • Humira Prefilled pen (Adalimumab) AbbVie (10c)
      40 mg/0.4 mL (Prefilled pen) [2]: Authority - PBS/RPBS
    • Humira Prefilled syringe (Adalimumab) AbbVie (10c)
      40 mg/0.4 mL (Prefilled syringe) [2]: Authority - PBS/RPBS
    • Hyrimoz Prefilled syringe (Adalimumab) Sandoz (10c)
      40 mg/0.4 mL (prefilled syringe) [2]: Authority - PBS/RPBS
      40 mg/0.8 mL (prefilled syringe) [2]: Authority - PBS/RPBS
    • Hyrimoz Sensoready Prefilled pen (Adalimumab) Sandoz (10c)
      40 mg/0.4 mL (prefilled pen) [2]: Authority - PBS/RPBS
      40 mg/0.8 mL (prefilled pen) [2]: Authority - PBS/RPBS
    • Korsuva Solution for injection (Difelikefalin) Seqirus (10c)
      50 mcg/mL 1 mL [12]: Section 100 (Highly Specialised Drugs) - Private - Authority
      50 mcg/mL 1 mL [12]: Section 100 (Highly Specialised Drugs) - Public - Authority
    • Revolade Tablets (Eltrombopag) Novartis (2l)
      25 mg [28] x 3: Section 100 (Highly Specialised Drugs) - Public - Authority
      25 mg [28] x 3: Section 100 (Highly Specialised Drugs) - Private - Authority
      50 mg [28] x 3: Section 100 (Highly Specialised Drugs) - Private - Authority
      50 mg [28] x 3: Section 100 (Highly Specialised Drugs) - Public - Authority
    • Tafinlar Capsules (Dabrafenib) Novartis (9f)
      50 mg [120] x 2: Authority - PBS/RPBS
      75 mg [120]: Authority - PBS/RPBS
    • Tafinlar Dispersible tablets (Dabrafenib) Novartis (9f)
      10 mg [210] x 2: Authority - PBS/RPBS
    • Tagrisso Tablets (Osimertinib) AstraZeneca (9f)
      80 mg [30]: Authority - PBS/RPBS
    • Vabysmo Solution for injection Vial (Faricimab) Roche (14g)
      6 mg/0.05 mL (28.8 mg/0.24 mL; vial) [1]: Authority - PBS/RPBS
    • Yuflyma Autoinjector Solution for injection (Adalimumab) Celltrion Healthcare (10c)
      40 mg/0.4 mL (autoinjector) [2]: Authority - PBS/RPBS
    • Yuflyma Prefilled syringe (Adalimumab) Celltrion Healthcare (10c)
      40 mg/0.4 mL (prefilled syringe with safety guard) [2]: Authority - PBS/RPBS
  • Bioequivalence Indicator changes:
    • Metalyse Powder for injection (Tenecteplase) Boehringer Ingelheim (2m)
      50 mg (+ 10 mL water for inj) [1]: Restricted - PBS/RPBS
    • Ordine Oral solution (Morphine hydrochloride trihydrate) Arrotex (4a)
      5 mg/mL 1 mL [200]: Restricted - PBS/RPBS
      5 mg/mL 1 mL [200] x 2: Authority (Streamlined) - Palliative Care
    • Puregon Solution for injection (Follitropin beta) Organon (6c)
      300 IU/0.36 mL (multidose cartridge) [1] x 2: Section 100 (IVF Treatment) - Authority (Streamlined)
      300 IU/0.36 mL (multidose cartridge) [1] x 3: Restricted - PBS/RPBS
      900 IU/1.08 mL (multidose cartridge) [1] x 2: Restricted - PBS/RPBS
      900 IU/1.08 mL (multidose cartridge) [1] x 5: Section 100 (IVF Treatment) - Authority (Streamlined)
    • Solu-Medrol Powder for injection (Methylprednisolone sodium succinate) Pfizer (6a)
      1 g (+ solv) [1]: PBS/RPBS
    • Systane Lubricating Eye drops (Polyethylene glycol 400; propylene glycol) Alcon (14f)
      15 mL [1]: Restricted - PBS/RPBS
      15 mL [1] x 2: Restricted - PBS/RPBS
    • Vabysmo Solution for injection Vial (Faricimab) Roche (14g)
      6 mg/0.05 mL (28.8 mg/0.24 mL; vial) [1]: Authority - PBS/RPBS
      6 mg/0.05 mL (28.8 mg/0.24 mL; vial) [1]: Authority (Streamlined) - PBS/RPBS
  • the latest MIMS Medicine Information
    • Over 182 updates or additions to the MIMS listings
    New listings include:
    • Abilify Asimtufii (Aripiprazole) Lundbeck (3c)
    • Amcal Nicotine Chewing Gum (Nicotine) Perrigo Australia (20b)
    • Amcal Nicotine Patches (Nicotine) Perrigo Australia (20b)
    • Amiodarone Hydrochloride Injection, USP (Slate Run, USA) (Amiodarone hydrochloride) Orspec (2d)
    • Amiodarone Solution for Injection or Infusion (Bowmed Ibisqus, UK) (Amiodarone hydrochloride) Link (2d)
    • Amvuttra (Vutrisiran) Medison Pharma (3e)
    • APOHealth Allergy and Hayfever Relief Nasal Spray (Azelastine; fluticasone propionate) Arrotex (13b)
    • ARX-Ezetimibe (Ezetimibe) Arrotex (2f)
    • Biltricide (Germany) (Praziquantel) Link (8l)
    • Chemists' Own Allermist (Azelastine; fluticasone propionate) Arrotex (13b)
    • Chemists' Own Cold & Flu Relief (Paracetamol; pseudoephedrine hydrochloride) Arrotex (11a)
    • Dexrazoxane-Reach (Dexrazoxane) Reach Pharma (9g)
    • Epkinly (Epcoritamab) AbbVie (9f)
    • Fabhalta (Iptacopan) Novartis (10c)
    • Fulvestrant SXP (Fulvestrant) Southern XP IP (9e)
    • Furosemide-Reach (Furosemide (frusemide)) Reach Pharma (2c)
    • Ganirelix Lupin (Ganirelix) Lupin (6c)
    • Metrol (Metoprolol tartrate) Arrotex (2b)
    • Midazolam Solution for Injection (Aguettant, France) (Midazolam) Aborns (3a)
    • Nebaloc (Nebivolol) Pharmacor (2b)
    • Oncaspar (Ireland) (Pegaspargase) Servier (9b)
    • Opsynvi (Macitentan; tadalafil) Janssen-Cilag (2n)
    • Oridopa (Levodopa; carbidopa) Orion Pharma (3f)
    • Paramyl Osteo (Paracetamol) Noumed (4b)
    • Pediapharm Naproxen Suspension, USP (Medexus Pharma, Canada) (Naproxen) Phero Pharma (5a)
    • Pharmacor Sacubitril/Valsartan (Sacubitril; valsartan) Pharmacor (2n)
    • Pharmacy Care Nicotine Chewing Gum (Nicotine) Perrigo Australia (20b)
    • Pharmacy Care Nicotine Patches (Nicotine) Perrigo Australia (20b)
    • PKU Glytactin Build 10 (multiple actives) Cortex (19b)
    • Pluvicto (Lutetium (177Lu) vipivotide tetraxetan) Novartis (9f)
    • Radicava (Edaravone) Teva (3e)
    • Rivaxib (Rivaroxaban) Alphapharm (2k)
    • Rystiggo (Rozanolixizumab) UCB Pharma (5f)
    • Sildenafil-DRLA (Sildenafil) Dr Reddy's (7e)
    • Syfovre (Pegcetacoplan) Apellis (14g)
    • Tambocor (Germany) (Flecainide acetate) Medsurge (2d)
    • Tranexamic Acid Waymade (Tranexamic acid) Waymade Australia (2l)
    • Valproate SXP (Sodium valproate) Southern XP IP (3g)
    • Valtresto (Sacubitril; valsartan) Pharmacor (2n)
  • the latest MIMS DrugAlert data
  • the latest CMIs
    • Over 485 updates or additions to the collection

 

  •   PRODUCTS

    We provide a wide range of products that give you the flexibility for the work environment you find yourself in whether you are at your desktop, on the move, need a book! Click here for details on all digital and print products.

  •   DECISION SUPPORT

    Independent of Product Information, these evidence based decision support modules are written by expert clinical staff and sourced from primary international literature covering important information for prescribing, dispensing and administering medicines such as interactions between two or more drugs. Click here for more details.

  •   MARKETS

    MIMS products are highly valued and utilised widely across Australia by healthcare professionals in public and private acute care, primary care, aged care, community services – just to name a few. Click here for full details on all the markets covered.

  •   NEWS

    For all the latest news, publications, and happenings with various products at MIMS...Click here.

    Link your eMIMSCloud to the
    Fred Dispense Plus App Bar today.
    Find out how adding eMIMS will help your work flow by watching this short video.
  • 1